Likewise, activation of renal TLR4 and NF-κB in the present study was demonstrated not only at 1 year of DM, but also as early as 2 months after STZ injection, at a time when established glomerular sclerotic lesions were absent. The gene discussed is NFKB1; the disease is diabetes mellitus.